Translational Research on Stem Cells for Parkinson's Disease

Abstract

Get full access to this article

View all access options for this article.

References

Garitaonandia

, Gonzalez

, Sherman

, Semechkin

, Evans

, and Kern

. (2018). Novel approach to stem cell therapy in Parkinson's disease. Stem Cells Dev, 27:951–957.

Loring

. (2018). Autologous induced pluripotent stem cell-derived neurons to treat Parkinson's disease. Stem Cells Dev, 27:958–959.

Vermilyea

and Emborg

. (2018). In vitro modeling of leucine-rich repeat kinase 2 (LRRK2) G2019S-mediated Parkinson's disease pathology. Stem Cells Dev, 27:960–967.

Schwamborn

. (2018). Is Parkinson's disease a neurodevelopmental disorder and will brain organoids help us to understand it?. Stem Cells Dev, 27:968–975.

Stanslowsky

, Tharmarasa

, Staege

, Kalmbach

, Klietz

, Schwarz

, Leffler

and Wegner

. (2018). Calcium, sodium, and transient receptor potential channel expression in human fetal midbrain-derived neural progenitor cells. Stem Cells Dev, 27:976–984.

Zasso

, Ahmed

, Cutarelli

and Conti

. (2018). Inducible alpha-synuclein expression affects human neural stem cells' behavior. Stem Cells Dev, 27:985–994.

Guo

, Chen

, Guderyon

, Liu

, He

, Yu

, Clark

and Li

. (2018). Regulatable lentiviral hematopoietic stem cell gene therapy in a mouse model of Parkinson's disease. Stem Cells Dev, 27:995–1005.